{"title":"AMCP Market Insights: Impact of the evolving understanding of multiple sclerosis and emerging treatment approaches on managed care.","authors":"Bridget Flavin, Justin Bioc, Janna Evans, Rebecca Lich, Timothy O'Shea, Hiva Pourarsalan","doi":"10.18553/jmcp.2025.31.8-a.s1","DOIUrl":null,"url":null,"abstract":"<p><p>Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS) and is associated with significant clinical and economic burden. Advancements in the understanding of the underlying biology of MS have important implications for both diagnosis and treatment. To discuss the impact of continuing developments in MS on managed care, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in December 2024. Key insights from the discussion related to supporting patient needs in MS, advancing understanding of MS, emerging treatments in MS, using real-world evidence in MS coverage decision-making, and addressing continued challenges in MS. Suggested payer best practices in MS also emerged from the discussion.</p>","PeriodicalId":16170,"journal":{"name":"Journal of managed care & specialty pharmacy","volume":"31 8-a Suppl","pages":"S1-S9"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12249916/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of managed care & specialty pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18553/jmcp.2025.31.8-a.s1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS) and is associated with significant clinical and economic burden. Advancements in the understanding of the underlying biology of MS have important implications for both diagnosis and treatment. To discuss the impact of continuing developments in MS on managed care, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in December 2024. Key insights from the discussion related to supporting patient needs in MS, advancing understanding of MS, emerging treatments in MS, using real-world evidence in MS coverage decision-making, and addressing continued challenges in MS. Suggested payer best practices in MS also emerged from the discussion.
期刊介绍：
JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
